- Home
- GIPR vs ISPC Comparison
GIPR vs ISPC Comparison
Compare GIPR & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIPR | ISPC |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Precision Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 5.7M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GIPR | ISPC |
|---|---|---|
| Price | $0.95 | $0.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 702.2K | 528.3K |
| Earning Date | 11-17-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,953,920.00 | $3,352,744.00 |
| Revenue This Year | $1.12 | $35.93 |
| Revenue Next Year | $0.52 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.78 | $0.39 |
| 52 Week High | $2.06 | $4.66 |
Technical Indicators
Market Signals| Indicator | GIPR | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 45.65 | 36.94 |
| Support Level | $0.89 | $0.39 |
| Resistance Level | $1.34 | $0.53 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 26.44 | 20.22 |
Price Performance
Historical ComparisonAbout GIPR Generation Income Properties Inc.
Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.